By Business/Source
Currency:USD
2026/Q2
Stock NameRevenueRatio
Discovery, development and commercialization of pharmaceutical products for the treatment of human692K100.00%
By Country/Region
Currency:USD
2025/FY
Stock NameRevenueRatio
United States49.8M100.00%